InflaRx N.V. (IFRX) Social Stream



InflaRx N.V. (IFRX): $2.80

0.10 (-3.45%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

F

Add IFRX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#242 of 359

in industry

INFLARX NV (IFRX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IFRX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-11 6 $16 $5 $11 $3.35 228.36%
2022-03-24 5 $15 $5 $9.75 $3.35 191.04%
2022-03-31 5 $15 $5 $9.25 $3.35 176.12%
2022-05-13 5 $15 $5 $8.25 $3.35 146.27%
2022-08-08 4 $8 $4 $6.333 $3.35 89.04%
2022-12-22 4 $8 $4 $6.666 $3.35 98.99%
2023-03-23 4 $8 $4 $6 $3.35 79.1%
2023-04-05 4 $10 $4 $7.333 $3.35 118.9%
2023-04-06 5 $25 $10 $15 $3.35 347.76%
2023-05-12 5 $25 $8 $13 $3.35 288.06%
2023-08-11 5 $21 $6 $11 $3.35 228.36%

The Trend in the Analyst Price Target


IFRX's average price target has moved up $2.25 over the prior 17 months.

IFRX reports an average of 151.15% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-05 4 25 10 15.000 6.1 145.9%
2023-04-05 4 10 4 7.333 6.1 20.21%
2023-04-06 5 25 10 15.000 5.5 172.73%
2023-05-12 5 21 8 11.500 5.1 125.49%
2023-05-12 5 25 8 13.000 5.1 154.9%

IFRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


IFRX's average broker recommendation rating improved by 0.5 over the prior 15 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IFRX as an investment opportunity.

  • In terms of how INFLARX NV fares relative to all US stocks, note that its average analyst price target is greater than 196.54% of that group.
  • To contextualize these metrics, consider that out of all US stocks, INFLARX NV's number of analysts covering the stock is higher than 364.76% of them.
  • To contextualize these metrics, consider that out of all US stocks, INFLARX NV's variance in analysts' estimates is lower than -1518.63% of them.
  • In terms of how INFLARX NV fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 1162.57% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to INFLARX NV are MBIO, EOLS, and ACET.

What is the outlook for IFRX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!